Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer — Stella

Home/Early Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Early Breast Cancer trials

Trial locations(2 sites)

Taiwan

National Taiwan University Hospital, Taipei, Taiwan

National Taiwan University Hospital Yunlin Branch, Taipei

Key details

Sponsor

National Taiwan University Hospital

Enrollment target

~315 participants

Started

February 2025

Primary completion

February 2027

Age range

20 Years – 85 Years

Sex

Female only

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.